{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:10Z","timestamp":1785307090431,"version":"3.55.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.1093\/cid\/civ084","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T11:45:46Z","timestamp":1429098346000},"page":"S30-S41","source":"Crossref","is-referenced-by-count":15,"title":["Estimating the United States Demand for Influenza Antivirals and the Effect on Severe Influenza Disease During a Potential Pandemic"],"prefix":"10.1093","volume":"60","author":[{"given":"Justin J.","family":"O'Hagan","sequence":"first","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC)"},{"name":"IHRC Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Epidemic Intelligence Service assigned to Influenza Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela P.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Epidemiology and Prevention Branch, Influenza Division, NCIRD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Strategic National Stockpile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC)"},{"name":"Modeling Unit and Office of the Director, NCIRD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Fry","sequence":"additional","affiliation":[{"name":"Epidemiology and Prevention Branch, Influenza Division, NCIRD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Koonin","sequence":"additional","affiliation":[{"name":"Influenza Coordination Unit, Office of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[{"name":"Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"2019041208582826300_CIV084C1","article-title":"Human infection with influenza A(H7N9) virus in China","author":"World Health Organization"},{"key":"2019041208582826300_CIV084C2","article-title":"Human infection with avian influenza A(H7N9) virus \u2013 update","author":"World Health Organization"},{"key":"2019041208582826300_CIV084C3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"2019041208582826300_CIV084C4","doi-asserted-by":"crossref","first-page":"f4752","DOI":"10.1136\/bmj.f4752","article-title":"Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation","volume":"347","author":"Qi","year":"2013","journal-title":"BMJ"},{"key":"2019041208582826300_CIV084C5","article-title":"HHS Pandemic Influenza Plan"},{"key":"2019041208582826300_CIV084C6","article-title":"The Canadian Pandemic Influenza Plan for the Health Sector","author":"Public Health Agency of Canada"},{"key":"2019041208582826300_CIV084C7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3201\/eid1906.121478","article-title":"Pandemic influenza planning, United States, 1978\u20132008","volume":"19","author":"Iskander","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2019041208582826300_CIV084C8","article-title":"Pandemic influenza preparedness and response, WHO guidance document","author":"World Health Organization"},{"key":"2019041208582826300_CIV084C9","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019041208582826300_CIV084C10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections","volume":"352","author":"Management of Influenza in the Southern Hemisphere Trialists Study Group","year":"1998","journal-title":"Lancet"},{"key":"2019041208582826300_CIV084C11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041208582826300_CIV084C12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial","volume":"19","author":"Hedrick","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"2019041208582826300_CIV084C13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archinte.161.2.212","article-title":"Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials","volume":"161","author":"Lalezari","year":"2001","journal-title":"Arch Intern Med"},{"key":"2019041208582826300_CIV084C14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections","volume":"180","author":"Monto","year":"1999","journal-title":"J Infect Dis"},{"issue":"suppl B","key":"2019041208582826300_CIV084C15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/44.suppl_2.23","article-title":"Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis","volume":"44","author":"Monto","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2019041208582826300_CIV084C16","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"2019041208582826300_CIV084C17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"2019041208582826300_CIV084C18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"2019041208582826300_CIV084C19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-156-7-201204030-00411","article-title":"Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies","volume":"156","author":"Hsu","year":"2012","journal-title":"Ann Intern Med"},{"key":"2019041208582826300_CIV084C20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/jis726","article-title":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009\u20132010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients","volume":"207","author":"Muthuri","year":"2013","journal-title":"J Infect Dis"},{"key":"2019041208582826300_CIV084C21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3201\/eid1901.120124","article-title":"Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics","volume":"19","author":"Reed","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2019041208582826300_CIV084C22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/civ088","article-title":"Standardizing scenarios to assess the need to respond to an influenza pandemic","volume":"60","author":"Meltzer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019041208582826300_CIV084C23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/infdis\/134.4.362","article-title":"Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968\u201374","volume":"134","author":"Foy","year":"1976","journal-title":"J Infect Dis"},{"key":"2019041208582826300_CIV084C24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"2019041208582826300_CIV084C25","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2105\/AJPH.2012.300651","article-title":"Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009\u20132010","volume":"102","author":"Biggerstaff","year":"2012","journal-title":"Am J Public Health"},{"key":"2019041208582826300_CIV084C26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/jiu224","article-title":"Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010\u201311 influenza season\u2014United States","volume":"210","author":"Biggerstaff","year":"2014","journal-title":"J Infect Dis"},{"key":"2019041208582826300_CIV084C27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3201\/eid1709.110295","article-title":"Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States","volume":"17","author":"Atkins","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2019041208582826300_CIV084C28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/cid\/cir400","article-title":"Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials","volume":"53","author":"Hernan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019041208582826300_CIV084C29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/656316","article-title":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry","volume":"202","author":"Adisasmito","year":"2010","journal-title":"J Infect Dis"},{"key":"2019041208582826300_CIV084C30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","article-title":"Incubation periods of acute respiratory viral infections: a systematic review","volume":"9","author":"Lessler","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2019041208582826300_CIV084C31","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.294.21.2712","article-title":"Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988\u20132002","volume":"294","author":"Fry","year":"2005","journal-title":"JAMA"},{"key":"2019041208582826300_CIV084C32","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/425615","article-title":"The burden of community-acquired pneumonia in seniors: results of a population-based study","volume":"39","author":"Jackson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2019041208582826300_CIV084C33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distribution of child deaths from acute respiratory infections","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2019041208582826300_CIV084C34","article-title":"Emergency Compounding of an Oral Suspension from Tamiflu Capsules"},{"key":"2019041208582826300_CIV084C35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18360","article-title":"Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds","volume":"18","author":"Nicholson","year":"2014","journal-title":"Health Technol Assess"},{"key":"2019041208582826300_CIV084C36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijantimicag.2010.01.006","article-title":"Treatment options for 2009 H1N1 influenza: evaluation of the published evidence","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2019041208582826300_CIV084C37","doi-asserted-by":"crossref","first-page":"e57265","DOI":"10.1371\/journal.pone.0057265","article-title":"The spread of influenza A(H1N1)pdm09 in Victorian school children in 2009: implications for revised pandemic planning","volume":"8","author":"Fielding","year":"2013","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1378\/chest.10-2792","article-title":"Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection","volume":"140","author":"Viasus","year":"2011","journal-title":"Chest"},{"key":"2019041208582826300_CIV084C39","doi-asserted-by":"crossref","first-page":"e67253","DOI":"10.1371\/journal.pone.0067253","article-title":"Using a dynamic model to consider optimal antiviral stockpile size in the face of pandemic influenza uncertainty","volume":"8","author":"Greer","year":"2013","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C40","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1098\/rsif.2010.0715","article-title":"Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective","volume":"8","author":"Carrasco","year":"2011","journal-title":"J R Soc Interface"},{"key":"2019041208582826300_CIV084C41","doi-asserted-by":"crossref","first-page":"e13797","DOI":"10.1371\/journal.pone.0013797","article-title":"The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A\/H1N1 2009","volume":"5","author":"Kelso","year":"2010","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"Ferguson","year":"2006","journal-title":"Nature"},{"key":"2019041208582826300_CIV084C43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3201\/eid0905.020321","article-title":"Pandemic influenza and healthcare demand in the Netherlands: scenario analysis","volume":"9","author":"van Genugten","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2019041208582826300_CIV084C44","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1073\/pnas.0601266103","article-title":"Mitigation strategies for pandemic influenza in the United States","volume":"103","author":"Germann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019041208582826300_CIV084C45","doi-asserted-by":"crossref","first-page":"e16094","DOI":"10.1371\/journal.pone.0016094","article-title":"Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza","volume":"6","author":"Dimitrov","year":"2011","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/biostatistics\/kxn045","article-title":"A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections","volume":"10","author":"Yang","year":"2009","journal-title":"Biostatistics"},{"key":"2019041208582826300_CIV084C47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2019041208582826300_CIV084C48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/bsp.2013.0012","article-title":"Broadening access to medical care during a severe influenza pandemic: the CDC nurse triage line project","volume":"11","author":"Koonin","year":"2013","journal-title":"Biosecur Bioterror"},{"key":"2019041208582826300_CIV084C49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1089\/tmj.2010.0102","article-title":"Can an office practice telephonic response meet the needs of a pandemic?","volume":"16","author":"North","year":"2010","journal-title":"Telemed J E Health"},{"key":"2019041208582826300_CIV084C50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1750-2659.2009.00128.x","article-title":"Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic","volume":"4","author":"Goldstein","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"2019041208582826300_CIV084C51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid2004.130725","article-title":"Efficiency of points of dispensing for influenza A(H1N1)pdm09 vaccination, Los Angeles County, California, USA, 2009","volume":"20","author":"Saha","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2019041208582826300_CIV084C52","doi-asserted-by":"crossref","first-page":"20121019","DOI":"10.1098\/rsif.2012.1019","article-title":"Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza","volume":"10","author":"Black","year":"2013","journal-title":"J R Soc Interface"},{"key":"2019041208582826300_CIV084C53","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1073\/pnas.0706849105","article-title":"Modeling targeted layered containment of an influenza pandemic in the United States","volume":"105","author":"Halloran","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019041208582826300_CIV084C54","article-title":"Influenza Antiviral Drug Resistance","author":"Centers for Disease Control and Prevention"},{"key":"2019041208582826300_CIV084C55","article-title":"Pandemic (H1N1) 2009 - update 66","author":"World Health Organization"},{"key":"2019041208582826300_CIV084C56","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.2807\/ese.18.15.20453-en","article-title":"Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013","volume":"18","author":"Kageyama","year":"2013","journal-title":"Euro Surveill"},{"key":"2019041208582826300_CIV084C57","doi-asserted-by":"crossref","first-page":"e30018","DOI":"10.1371\/journal.pone.0030018","article-title":"Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway\u2014and the influence of vaccination timing","volume":"7","author":"Blasio","year":"2012","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/1471-2458-13-669","article-title":"Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?","volume":"13","author":"Greer","year":"2013","journal-title":"BMC Public Health"},{"key":"2019041208582826300_CIV084C59","doi-asserted-by":"crossref","first-page":"e22087","DOI":"10.1371\/journal.pone.0022087","article-title":"Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics","volume":"6","author":"Halder","year":"2011","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2458-13-211","article-title":"Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories","volume":"13","author":"Kelso","year":"2013","journal-title":"BMC Public Health"},{"key":"2019041208582826300_CIV084C61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1741-7015-7-76","article-title":"Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies","volume":"7","author":"Lee","year":"2009","journal-title":"BMC Med"},{"key":"2019041208582826300_CIV084C62","doi-asserted-by":"crossref","first-page":"e61504","DOI":"10.1371\/journal.pone.0061504","article-title":"The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis","volume":"8","author":"Milne","year":"2013","journal-title":"PLoS One"},{"key":"2019041208582826300_CIV084C63","article-title":"Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions","author":"Department of Health and Human Services & Centers for Disease Control and Prevention"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/60\/suppl_1\/S30\/28369544\/civ084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T03:31:51Z","timestamp":1651721511000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/60\/suppl_1\/S30\/356485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":63,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2015,4,10]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ084","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,5,1]]},"published":{"date-parts":[[2015,4,10]]}}}